RNAC Cartesian Therapeutics, Inc.

Fundamentals / CIK 0001453687 / USD

Cartesian Therapeutics, Inc. reported $1.02M in revenue and a net loss of $127.5M for the trailing twelve months ended September 30, 2026 (down 100.0% year over year), with a -15540.9% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open RNAC in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$132.4M$66.19M$0-$214.8MFY 2016 Revenue: $8.08MFY 2016 Net Income: -$36.21M2016FY 2017 Revenue: $207KFY 2017 Net Income: -$65.32M2017FY 2018 Revenue: $903KFY 2018 Net Income: -$65.34M2018FY 2019 Revenue: $6.68MFY 2019 Net Income: -$55.35M2019FY 2020 Revenue: $16.60MFY 2020 Net Income: -$68.88M2020FY 2021 Revenue: $85.08MFY 2021 Net Income: -$25.69M2021FY 2022 Revenue: $110.8MFY 2022 Net Income: $35.38M2022FY 2023 Revenue: $26.00MFY 2023 Net Income: -$219.7M2023FY 2024 Revenue: $38.91MFY 2024 Net Income: -$77.42M2024FY 2025 Revenue: $2.80MFY 2025 Net Income: -$130.3M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $2.80M $38.91M $26.00M $110.8M $85.08M $16.60M $6.68M $903K $207K $8.08M
Research & Development $58.03M $45.10M $71.26M $72.38M $68.74M $54.51M $42.74M $47.69M $45.16M $29.70M
Total Operating Expenses $146.2M $82.81M $112.4M $96.24M $89.67M $73.42M $59.13M $65.92M $63.99M $42.75M
Operating Income -$143.4M -$43.90M -$86.42M $14.54M -$4.60M -$56.82M -$52.45M -$65.02M -$63.78M -$34.67M
EBITDA -$141.0M -$42.70M -$85.72M $15.24M -$4.00M -$56.22M -$51.76M -$64.02M -$63.03M -$33.87M
Interest Income $6.58M $7.39M $4.96M -- -- -- -- -- -- --
Interest Expense -- $0 $2.83M $3.03M $2.84M $1.56M $1.52M $1.49M $1.21M $1.25M
Income Before Tax -$139.5M -$77.14M -$238.7M $34.77M -$9.72M -$68.88M -$55.35M -- -- --
Income Tax Expense -$9.19M $287K -$19.00M -$609K $15.97M $0 $0 -- -- --
Net Income -$130.3M -$77.42M -$219.7M $35.38M -$25.69M -$68.88M -$55.35M -$65.34M -$65.32M -$36.21M
Basic EPS -$5.02 -$4.48 -$49.76 $7.21 -$6.61 -$20.42 -$36.64 -$87.69 -$96.10 -$116.82
Diluted EPS -$5.02 -$4.49 -$49.76 $3.00 -$6.61 -$20.42 -$36.64 -$87.69 -$96.10 -$116.82
Basic Shares Outstanding 26.0M 17.3M 5.2M 4.8M 3.8M 3.4M 1.5M 745.6K 680.2K 349.4K
Diluted Shares Outstanding 26.0M 17.4M 5.2M 4.9M 3.8M 3.4M 1.5M 745.6K 680.2K 349.4K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $78K $947K $452K $298K $1.10M -$759K
Research & Development $15.62M $20.43M $19.46M $14.69M $13.80M $14.87M $14.67M $11.31M
Total Operating Expenses $25.00M $29.16M $26.58M $79.59M $21.52M $22.11M $22.99M $25.97M
Operating Income -$25.00M -$29.16M -$26.50M -$78.64M -$21.07M -$21.81M -$21.89M -$26.73M
EBITDA -$24.20M -$28.36M -$25.90M -$78.04M -$20.47M -$21.21M -$21.29M -$26.23M
Interest Income $1.20M $1.10M $1.03M $1.27M $1.55M $1.75M $2.02M --
Interest Expense $1.99M $852K -- -- $0 $0 -- --
Net Income -$11.47M $15.77M -$39.18M -$92.58M -$35.90M $15.89M -$17.71M -$10.25M
Basic EPS -$0.38 $0.47 -$1.46 -- -$1.38 $0.51 -$0.68 --
Diluted EPS -$0.38 $0.46 -$1.46 -- -$1.38 $0.50 -$0.68 --
Basic Shares Outstanding 30.3M 29.5M 26.9M -- 26.0M 26.0M 25.9M --
Diluted Shares Outstanding 30.3M 29.9M 26.9M -- 26.0M 26.4M 25.9M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Jan 1 Dec 31
Cash & Cash Equivalents $125.1M $212.6M $76.91M $106.4M $114.1M $138.7M $89.89M $37.40M -- $70.62M
Short-Term Investments -- -- $0 $28.16M $14.00M $0 -- $0 $25.94M $25.94M
Cash & Short-Term Investments $125.1M $212.6M $76.91M $134.6M $128.1M $138.7M $89.89M $37.40M -- $96.56M
Accounts Receivable, Net $1.11M $872K $5.87M $6.60M $9.91M $7.22M $5.00M $0 $63K $63K
Other Current Assets -- -- -- -- -- -- -- $80K -- --
Total Current Assets $129.3M $216.6M $90.73M $148.1M $144.4M $151.3M $96.67M $42.08M $98.68M $98.68M
Property, Plant & Equipment, Net $12.19M $9.91M $2.11M $2.79M $2.14M $1.40M $1.22M $2.13M $2.09M $2.09M
Goodwill $48.16M $48.16M $48.16M $0 -- -- -- -- -- --
Other Non-Current Assets -- $518K $0 -- -- -- -- -- -- $0
Total Non-Current Assets $167.1M $218.4M $214.3M $17.75M $15.44M $14.09M $2.90M $2.41M $2.42M $2.42M
Total Assets $296.4M $435.0M $305.1M $165.9M $159.9M $165.4M $99.57M $44.48M $101.1M $101.1M
Accounts Payable $1.29M $288K $3.15M $316K $224K $443K $500K $1.10M $1.61M $1.61M
Deferred Revenue (Current) -- $0 $2.31M $593K $53.88M $72.05M $1.67M $959K $787K $787K
Total Current Liabilities $14.94M $22.98M $68.21M $25.08M $72.25M $81.55M $34.94M $35.14M $10.97M $10.97M
Long-Term Debt $0 -- -- -- -- -- -- -- -- --
Deferred Revenue (Non-Current) -- $0 $3.54M $0 $11.42M $38.75M $14.68M $13.82M $14.09M $15.92M
Other Non-Current Liabilities -- -- -- -- -- -- $0 $938K $1.20M $1.20M
Total Non-Current Liabilities $407.7M $418.8M $376.5M $46.98M $65.11M $101.9M $56.23M $14.76M $36.48M $38.31M
Total Liabilities $422.7M $441.8M $444.7M $72.06M $137.4M $183.4M $91.17M $49.90M $47.46M $49.29M
Total Debt (incl. Leases) $12.68M $13.98M $10.96M $11.66M $9.65M $10.55M $372K -- -- --
Common Stock $3.0K $3.0K $1.0K $15K $12K $11K $9.0K $3.0K $3.0K $3.0K
Retained Earnings -$822.4M -$692.1M -$614.6M -$394.9M -$430.3M -$404.6M -$335.8M -$280.4M -$215.1M -$216.9M
Accumulated Other Comp. Income -$4.58M -$4.62M -$4.60M -$4.56M -$4.57M -$4.56M -$4.52M -$4.56M -$4.42M -$4.42M
Total Stockholders' Equity -$126.2M -$6.80M -$440.2M $93.83M $22.52M -$18.01M $8.40M -$5.42M $53.64M $51.81M
Total Equity -$126.2M -$6.80M -$440.2M $93.83M $22.52M -$18.01M $8.40M -$5.42M $53.64M $51.81M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $123.0M $147.6M $118.6M $125.1M $143.4M $160.3M $180.4M $212.6M
Cash & Short-Term Investments $123.0M $147.6M $118.6M $125.1M $143.4M $160.3M $180.4M $212.6M
Accounts Receivable, Net $52K $196K $261K $1.11M $722K $354K $1.76M $872K
Total Current Assets $131.5M $153.6M $122.0M $129.3M $147.3M $163.4M $185.1M $216.6M
Property, Plant & Equipment, Net $10.73M $11.31M $11.64M $12.19M $12.39M $12.29M $10.17M $9.91M
Goodwill $48.16M $48.16M $48.16M $48.16M $48.16M $48.16M $48.16M $48.16M
Other Non-Current Assets -- -- -- -- -- $5.55M $6.05M $518K
Total Non-Current Assets $162.8M $165.0M $166.4M $167.1M $225.4M $225.5M $224.0M $218.4M
Total Assets $294.3M $318.6M $288.4M $296.4M $372.7M $388.9M $409.1M $435.0M
Accounts Payable $105K $1.05M $1.60M $1.29M $2.23M $454K $2.10M $288K
Deferred Revenue (Current) -- -- -- -- -- -- -- $0
Total Current Liabilities $15.70M $20.55M $15.95M $14.94M $13.80M $12.26M $15.00M $22.98M
Long-Term Debt $50.22M $52.85M -- $0 -- -- -- --
Deferred Revenue (Non-Current) -- -- -- -- -- -- -- $0
Total Non-Current Liabilities $409.1M $423.3M $420.6M $407.7M $394.7M $379.2M $415.9M $418.8M
Total Liabilities $424.8M $443.9M $436.5M $422.7M $408.5M $391.4M $430.9M $441.8M
Total Debt (incl. Leases) $60.34M $63.85M $11.86M $12.68M $12.60M $13.35M $14.07M $13.98M
Common Stock $3.0K $3.0K $3.0K $3.0K $3.0K $3.0K $3.0K $3.0K
Retained Earnings -$857.3M -$845.8M -$861.6M -$822.4M -$729.8M -$693.9M -$709.8M -$692.1M
Accumulated Other Comp. Income -$4.62M -$4.61M -$4.58M -$4.58M -$4.59M -$4.58M -$4.59M -$4.62M
Total Stockholders' Equity -$130.5M -$125.2M -$148.1M -$126.2M -$35.84M -$2.53M -$21.79M -$6.80M
Total Equity -$130.5M -$125.2M -$148.1M -$126.2M -$35.84M -$2.53M -$21.79M -$6.80M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$130.3M -$77.42M -$219.7M $35.38M -$25.69M -$68.88M -$55.35M -$65.34M -$65.32M -$36.21M
Depreciation & Amortization $2.40M $1.20M $700K $700K $600K $600K $700K $1.00M $750K $802K
Stock-Based Compensation $10.52M $6.58M $22.52M $11.19M $7.72M $5.42M $5.16M $5.71M $4.08M $2.05M
Change in Receivables -$243K $5.00M $726K $3.32M -$2.69M -$2.22M -$5.00M $0 $152K $610K
Change in Payables $1.07M -$2.93M $2.83M $92K -$219K -$57K -$600K -$516K -$2.33M $2.69M
Operating Cash Flow -$73.94M -$23.67M -$51.16M -$31.63M -$60.38M $34.88M -$51.44M -$59.16M -$52.03M -$19.76M
Capital Expenditure -$5.45M -$9.09M -$206K -$1.20M -$1.08M -$815K -$47K -$884K -$733K -$586K
Free Cash Flow -$79.39M -$32.77M -$51.37M -$32.83M -$61.47M $34.07M -$51.48M -$60.05M -$52.76M -$20.34M
Purchases of Investments -- -- $0 -$33.50M -$30.45M $0 -$18.19M -- -- --
Sales & Maturities of Investments -- -- -- -- $16.40M $0 $18.34M -- -- --
Investing Cash Flow -$5.45M -$8.74M $34.61M -$15.00M -$17.14M -$741K $229K $25.27M -$2.10M -$22.10M
Common Stock Issued -- -- -- $2.12M $51.96M $2.11M $30.94M $0 $10.00M $2.74M
Financing Cash Flow -$8.05M $168.4M -$13.14M $39.22M $52.90M $14.43M $105.0M $697K $66.02M $67.66M
Net Change in Cash -$87.41M $136.0M -$29.75M -$7.40M -$24.63M $48.51M $53.87M -$33.34M $11.98M $26.27M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$11.47M $15.77M -$39.18M -$92.58M -$35.90M $15.89M -$17.71M -$10.25M
Depreciation & Amortization $800K $800K $600K $600K $600K $600K $600K $500K
Stock-Based Compensation $2.66M $2.08M $2.42M $2.14M $2.59M $3.28M $2.51M $1.86M
Change in Receivables $144K $65K $854K -$393K -$368K $1.41M -$893K $3.96M
Change in Payables -$720K -$773K $310K -$933K $1.77M -$1.59M $1.82M -$237K
Operating Cash Flow -$27.73M -$21.08M -$22.14M -$17.71M -$15.60M -$17.52M -$23.11M -$7.00M
Capital Expenditure -$441K -$272K -$27K -$492K -$1.29M -$2.60M -$1.07M -$705K
Free Cash Flow -$28.17M -$21.35M -$22.16M -$18.20M -$16.89M -$20.12M -$24.18M -$7.71M
Investing Cash Flow -$441K -$272K -$27K -$492K -$1.29M -$2.60M -$1.07M -$354K
Common Stock Issued $3.44M $3.92M $15.39M -- $0 $0 $0 --
Financing Cash Flow $3.56M $50.34M $15.67M -$52K -$38K $60K -$8.03M $783K
Net Change in Cash -$24.63M $28.96M -$6.50M -$18.25M -$16.94M -$20.04M -$32.18M -$6.59M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -5127.1% -112.8% -332.3% 13.1% -5.4% -342.4% -785.6% -7200.7% -30813.5% -428.9%
Net Profit Margin -4658.6% -199.0% -844.9% 31.9% -30.2% -415.0% -829.0% -7235.4% -31556.0% -448.0%
Return on Equity (ROE) -- -- -- 37.7% -114.1% -- -659.2% -- -126.1% -65.9%
Return on Assets (ROA) -44.0% -17.8% -72.0% 21.3% -16.1% -41.6% -55.6% -146.9% -64.6% -40.5%
Current Ratio 8.65x 9.43x 1.33x 5.91x 2.00x 1.86x 2.77x 1.20x 8.99x 6.33x
Quick Ratio 8.45x 9.29x 1.21x 5.63x 1.91x 1.79x 2.72x 1.06x 8.81x 6.15x
Debt to Equity -- -- -- 0.12x 0.43x -- 0.04x -- -- --
Revenue Growth (YoY) -92.8% +49.6% -76.5% +30.2% +412.6% +148.6% +639.4% +336.2% -97.4% +34.5%
Operating Income Growth (YoY) -- -- -694.4% -- -- -- -- -- -- --
Net Income Growth (YoY) -- -- -721.0% -- -- -- -- -- -- --
EPS Growth (YoY) -- -- -790.4% -- -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -273.1% -- -- -- -- --
Free Cash Flow Growth (YoY) -- -- -- -- -280.4% -- -- -- -- --
5Y Revenue / Share Growth -97.8% -48.8% +315.3% +7450.9% -3.4% -94.1% -60.7% -- -- --
10Y Revenue / Share Growth -99.9% -79.9% -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -15540.9% -10518.6% -8338.9% -5127.1% -8386.5% -8577.6% -153.4% -112.8%
Net Profit Margin -12435.2% -10283.8% -8550.6% -4658.6% -4397.7% -3534.1% -112.1% -199.0%
Return on Assets (ROA) -43.3% -47.7% -52.6% -44.0% -12.9% -9.3% -9.4% -17.8%
Current Ratio 8.38x 7.48x 7.65x 8.65x 10.67x 13.33x 12.34x 9.43x
Quick Ratio 7.84x 7.19x 7.46x 8.45x 10.44x 13.11x 12.15x 9.29x
Revenue Growth (YoY) -100.0% -100.0% -92.9% -- +16.8% -99.1% -81.2% -109.2%
Operating Income Growth (YoY) -- -- -- -- -- -258.5% -- --
Net Income Growth (YoY) -- -0.7% -- -- -- +14.8% -- --
EPS Growth (YoY) -- -7.8% -- -- -- -12.1% -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -213.9% -- -- --
Free Cash Flow Growth (YoY) -- -- -- -- -325.5% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001453687) · from December 31, 2014 Data through September 30, 2026 · synced Nov 20, 2026, 05:44 UTC · Open in terminal